This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Vitadx International, Institut Pasteur. Active years: 2025.
Company Filing History:

Years Active: 2025
Title: Thibaut Troude: Innovator in Biological Sample Analysis
Introduction
Thibaut Troude is a notable inventor based in Paris, France. He has made significant contributions to the field of biological sample analysis, particularly in the detection and classification of abnormalities in cells. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics.
Latest Patents
Thibaut Troude's latest patents include a method for identifying abnormalities in cells of interest in a biological sample and a systematic characterization of objects in a biological sample. The first patent describes a computer-implemented device designed for the analysis of digital cytology slides from biological samples. This device is particularly focused on detecting cells of interest and calculating a global prediction score for the presence and stage of bladder cancer. The second patent outlines a method for classifying and counting objects from a urine sample processed onto a slide. This method involves receiving digitalized images, detecting connected components, and classifying them into countable and uncountable components.
Career Highlights
Throughout his career, Thibaut Troude has worked with reputable organizations such as Vitadx International and Institut Pasteur. His experience in these institutions has contributed to his expertise in biological sample analysis and innovation in medical technology.
Collaborations
Thibaut has collaborated with notable colleagues, including Riadh Fezzani and Marin Scalbert. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Thibaut Troude is a distinguished inventor whose work in biological sample analysis is making a significant impact in the medical field. His innovative patents and collaborations reflect his commitment to advancing diagnostic technologies.